Kozni ambulance Kutna Hora, s.r.o.
About Kozni ambulance Kutna Hora, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Pfizer
3
Aristea Therapeutics, Inc.
1
Janssen Research & Development, LLC
1
Clinical Trials at Kozni ambulance Kutna Hora, s.r.o.
During the past decade, Kozni ambulance Kutna Hora, s.r.o. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
2017-04-27
2018-09-20
Completed
1,048
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
2018-03-28
2023-08-07
Active, not recruiting
1,645
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
2017-12-07
2019-03-26
Completed
387
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
2018-06-26
2020-06-03
Completed
1,484
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
2018-09-03
2022-02-07
Terminated
1,936
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
2019-02-18
2020-04-08
Completed
287
A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
2022-01-05
2023-03-06
Terminated
79
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kozni ambulance Kutna Hora, s.r.o."
#1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kozni ambulance Kutna Hora, s.r.o.
According to Clinical.Site data, the most researched conditions in "Kozni ambulance Kutna Hora, s.r.o." are
"Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials) and "Palmoplantar Pustulosis" (1 trials). Many other conditions were trialed in "Kozni ambulance Kutna Hora, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at Kozni ambulance Kutna Hora, s.r.o.
Most popular intervention types in "Kozni ambulance Kutna Hora, s.r.o." are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Mirikizumab" (2 trials), "Secukinumab" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kozni ambulance Kutna Hora, s.r.o.
The vast majority of trials in "Kozni ambulance Kutna Hora, s.r.o." are
8 trials for "All" genders.
Clinical Trials Status at Kozni ambulance Kutna Hora, s.r.o.
Currently, there are NaN active trials in "Kozni ambulance Kutna Hora, s.r.o.".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Kozni ambulance Kutna Hora, s.r.o.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kozni ambulance Kutna Hora, s.r.o., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".